ABSTRACT Immune responses are critical for protection of chickens from infectious bursal disease (IBD). In this study, the antibody response-enhancing effect of drinking water supplementation of 1% stinging nettle and neem on different IBD vaccines and vaccination regimes was evaluated, using 36 (n = 36) specific antibody negative indigenous chicks. The birds were allocated into 3 groups as follows: 1A-C, 2A-C, and 3A-B, while group 3C acted as the unvaccinated nonsupplemented control. A local inactivated K1 and imported live attenuated D78 IBD vaccines were given to groups 1A-C and 3A-B at 14 and 28 d of age, respectively. A combination of K1 and D78 vaccines was given 30 d apart to groups 2A and 2B (D78 at 14 and 21 d and K1 at 44 d of age) and on the same d to group 2C at 14 and 28 d of age. Stinging nettle was given in water to groups 1B, 2B, and 2C, and neem to groups 1C, 2A, and 3B. Birds were bled weekly and immune responses monitored using indirect ELISA. Both neem and stinging nettle had antibody response-enhancing effects in groups 1B and 1C, receiving the local inactivated K1 vaccine. There were significant differences (P < 0.05) in antibody titers between groups 1A and 2C. Stinging nettle induced earlier onset of high antibody responses in group 2C and persistent titers (>3.8 log 10 ) from the third week in group 2B. Imported live D78 vaccine induced higher antibody titers compared to the local inactivated K1 vaccine. Groups 2B and 2C receiving a combination of the local K1 and imported live attenuated D78 vaccines had the highest antibody titers. Adoption of stinging nettle supplementation and a prime-boost program involving use of a local virus isolates-derived vaccine is recommended.
INTRODUCTION
Indigenous chickens form the backbone of rural economies and contribute about 71% of the total egg and poultry meat produced in Kenya (Nyaga, 2007) . Further improvement of their production potential is, however, hindered by viral diseases, among which infectious bursal disease (IBD), or gumboro, is a major cause of economic losses, second only to Newcastle disease (Mutinda et al., 2013; Olwande et al., 2016) . IBD is an immunosuppressive viral infection of young chickens aged between 3 and 6 wk (Otsyina et al., 2009) . There is no specific treatment for the disease, while vaccination and proper biosecurity measures remain its main methods of control in poultry production systems around the world (AU-IBAR, 2013; El-mahdy et al., 2013) . In Kenya, indigenous and commercial layer type chickens incur the heaviest losses due to IBD, with mortalities reported at 39.2% and 31.1%, respectively (Mutinda et al., 2013) . The high IBD-induced mortalities witnessed in indigenous chickens affect the economy of the poor, especially women and youth, who largely own these birds (Olwande et al., 2016) ; therefore, any interventions aimed at reducing mortalities are vital to rural farmers.
To face the IBD virus challenge, chickens require protection provided by vaccination using correct vaccines adapted to local challenge conditions (FAO, 2006) . Nevertheless, there are IBD and other poultry vaccines imported into the local markets that may not conform antigenically to local pathogen biotypes (FAO, 2006) . Kenyan chicken farmers have used these imported live attenuated IBD vaccines with limited success in containing the disease, since new outbreaks are still reported even among vaccinated flocks due to vaccine 447 failure (Mutinda et al., 2013 (Mutinda et al., , 2014 . This may be due to 2 reasons: (1) the local field strains of the virus may be of different antigenic constitution, or (2) the local field strains may have acquired increased virulence, both being due to a possible genetic variation (Parker and Sjaak, 2014; Mutinda et al., 2014; Gardin et al., 2015) . The reported vaccination failures in local poultry have therefore put to question the efficacy and effectiveness of the existing imported vaccines, which may not be stimulating adequate immune responses in birds in Kenya nor surmounting the challenge of local virulent strains of the IBD virus (IBDV) (Mutinda et al., 2014) .
Vaccine failure in poultry occurs when chickens do not mount adequate immune responses and remain susceptible to field disease outbreaks following vaccination (Butcher and Miles, 2014) . The most common factors responsible for vaccine failures in commercial poultry include: vaccine virus strain and vaccine quality issues; vaccine administration issues; maternal antibodies; immunosuppression; and stress (Riks et al., 2001; Hussain et al., 2003; Parker and Sjaak, 2014) . Interventions aimed at incorporating local circulating virus strains in vaccines and improving chicken immune response to such vaccines may help mitigate the problem of exotic vaccine failure. Studies on plant-derived extracts of neem (Azadirachta indica) have highlighted its possible antiviral, growth-promoting (Alam et al., 2015) , and immune-modulating properties in poultry (Jawad et al., 2013; Kwawukume et al., 2013) . The leaves of stinging nettle (Urtica dioica) are an excellent source of easily available protein and vitamins (Eskedar et al., 2013; Bekele et al., 2015) . These plant leaves, tubers, and roots have gained increasing attention in poultry production systems due to their sustainability, low cost, lack of residual effects, and freedom from antimicrobial residues (Dharma et al., 2015) . However, in Kenya, little research has been done on the possible use of stinging nettle and neem as immune stimulants for poultry vaccines. The aim of this study was to assess the capacity of neem and stinging nettle in enhancing immune responses to a killed vaccine derived from local IBD virus isolates and an imported live D78 IBD vaccine under different vaccination regimes, with the secondary aim of establishing the best vaccination regime.
MATERIALS AND METHODS

Study Site
The study was based at the Department of Veterinary Pathology, Microbiology, and Parasitology in the College of Agriculture and Veterinary Sciences of the University of Nairobi, Upper Kabete Kenya.
Care and Use of Animals
All animal (chicken) experiments were conducted with the approval of and according to the University of Nairobi's Faculty of Veterinary Medicine Biosafety, Animal Care and Use Committee guidelines.
Indigenous Chicken
Specific antibody negative (SAN) day-old indigenous chicks (n = 36) were obtained from a local hatchery where chickens had not been vaccinated against IBD. The birds were randomly allocated into 3 groups (Groups 1A, B, and C; Groups 2A, B, and C; and Groups 3A, B, and C) kept in 3 separate rooms serving as isolation units to avoid cross-contamination. Each group had 4 wing-tagged birds kept in separate, labeled cages. Water was provided ad libitum, and the birds were fed a standardized diet of chick and duck mash (CP 19%, CF 6%, EE 6%, ME 2900 KCal/kg, Ca 1%, P 0.45%, Lys 0.85%, Met 0.36%, and traces of coccidiostats, UNGA Feeds Ltd. Kenya).
Infectious Bursal Disease Vaccines
The imported live attenuated IBD vaccine Jovac D78 (10 3.0 TCID50 IBDV strain D78, Jordan Bioindustries Center, 43, Amman 11,941-Jordan) was procured from local agrovet shops. Local inactivated K1 (10 2.90 EID 50 /0.2 ml) was prepared from 4 local isolates of IBDV (designated E7, E9, E19, and E42) collected from field outbreaks across the country and proven as good vaccine candidates based on their virulence and pathogenicity profiles in a previous study by Mutinda et al. (2016) . The local IBDV isolates were propagated in 4-week-old SAN indigenous chickens whose bursas of Fabricius were collected 72 h after inoculation and homogenized to make 20% antibiotic treated (1,000 units/mL, streptomycin-penicillin) bursal homogenate virus suspension, as described by Mutinda et al. (2016) and OIE (2008) . The bursal homogenate suspensions were pooled, and the virus titer (10 2.90 EID 50 /0.2 mL) determined by the SpearmanKaeber method (Dougherty, 1964) after inoculation of White Leghorn eggs. The pooled bursal virus suspension was used to prepare the inactivated local IBD vaccine (K1) as described by Mutinda et al. (2016) and modified by Bwana et al. (2017) . Briefly, 10 μL of 40% formalin was added to 1990 μL of the local IBD virus suspension to make a final concentration of 0.2%, incubated for 48 h at room temperature to inactivate the virus, and clarified by filtration through 0.22 μm pore filters; the resultant inactivated vaccine was stored at 4
• C until used (Mutinda et al., 2016; Bwana et al., 2017) . The local killed K1 IBD vaccine was prepared in the virology research laboratory one wk prior to handling and grouping the experimental birds. All infectious specimens and materials from the process were handled using gloves in a biosafety cabinet and disinfected using 10% omnicide solution before disposal to avoid cross-contamination.
Preparation of 1% Aqueous Stinging Nettle and Neem
Neem and stinging nettle powders were sourced from local supermarket chains and reconstituted by boiling in water at 10 g/liter, cooling, and filtering using gauze before feeding to the experimental birds as drinking water ad libitum one wk prior to vaccination (from 7 d of age) and throughout the experimental period of 7 wk (28 June 2016 to 16 August 2016). The aqueous 1% immune stimulant solutions were fed as follows: r 1% neem: Groups 1C, 2A, and 3B r 1% stinging nettle: Groups 1B, 2B, and 2C
Aqueous extracts of 1 to 2% stinging nettle (Safamehr et al., 2012) and 6% neem (Durrani et al., 2008; Nnenna and Okey, 2013) have been reported to have no toxic effects on chickens; hence the 1% was chosen for safety and comparative purposes.
Experimental Design and Vaccination Protocols
Thirty-six (n = 36) SAN indigenous chicks were randomly allocated into 3 groups comprising treatment groups (Groups 1A, B, and C; Groups 2A, B, and C; and Groups 3A and B) and a control group 3C. Groups 1 A, B, and C were used to test for the effect of the stimulants on the local inactivated K1 IBD vaccine and received K1 at 14 d of age and booster doses 14 d later. Groups 2A, B, and C tested for the effect of the stimulants on a combination of the imported live D78 and local inactivated K1 IBD vaccines. Groups 2A and 2B received booster K1 30 d (44 d of age) after priming with D78 at 14 and 21 d of age. Group 2C received D78 and K1 on the same d (14 d of age) and was boosted 14 d later with same combination. Groups 3A and B tested for the effect of the stimulants on the imported live D78 IBD vaccine and received D78 at 14 d of age with booster doses given 14 d later. Groups 3C acted as the unvaccinated control. The local inactivated K1 IBD vaccine was administered intramuscularly (I.M) in the breast muscles at 0.3 mL (10 2.90 EID 50 /0.2 mL) per bird. The imported live attenuated D78 R IBD vaccine was reconstituted in skimmed milk and distilled water at a rate of one heaped teaspoonful of skimmed milk in 4 liters of water and administered as drinking water for 2 h to respective groups in which water had been withdrawn 3 h previously. The experimental design and vaccination protocol were as shown in Table 1 .
Sample Collection and Processing
Birds were bled from the wing vein using gauge 23 needles on d zero, 7, 14, 28, 35, 42 , and 49 post first vaccinations. Serum was separated and stored at −20
• C until use. An enzyme-linked immunoassay test 
D78: imported live attenuated IBD vaccine; K1: local isolates derived killed IBD vaccine; + = given; -= not given; D78. . . K1 = given 30 d apart; D78+K1 = given on the same d. kit i.e., IDEXX IBD-XR ELISA kit (IDEXX Laboratories, Inc. Westbrook, ME), was used in the quantitation of antibody levels to the IBD vaccines in collected serum according to the manufacturer's instructions. Results of the assay in terms of optical densities (OD) were read photometrically using a standard ELISA reader (Titertek Multiskan Plus, Helsinki, Finland) at absorbency wavelength of 620 nm (supplementary data) and used to determine samples-topositive-serum (S/P) ratio ODs. Negative control mean and positive control mean were calculated and employed for determining the relative level of antibody in the S/P ratio using the formula: 
Log 10 transformed ELISA end point titers were calculated using the formula:
Log 10 Titer = 1.09 (log 10 S/P) + 3.36 (IDEXX IBD − XR Ab kit) (2) Serum samples with titers greater than 396 (>+2.6 log 10 ) were considered positive (diagnostic titer) and indicated vaccination or exposure to IBDV. Lack of exposure to IBDV or a negative score was given to all samples with a reaction of less than 0.2 S/P ratios (titers <396 or <2.6 log 10 ) (IDEXX IBD-XR Ab Test Kit guide).
Data Management and Analysis
Data on weekly IBDV ELISA antibody titers post vaccination for the 2 IBD vaccines were analyzed using Instat+ v3.36 statistical package. The log 10 transformed ELISA antibody titers were statistically converted into mean weekly titers and standard deviations for each group (Nauta et al., 2009 ). Differences and variations in mean weekly ELISA antibody titer levels between and among groups were compared using Student's t test and ANOVA, P < 0.05 being considered statistically significant. Rapidity of onset of high antibody levels was determined by comparing the weekly ELISA antibody titer levels with a threshold level of IBD antibody titer above which chicks were assumed to be protected and below which they were not (Botus et al., 2010; WHO, 2013) . The threshold antibody titer was taken to be 1,500, equivalent to 3.18 log 10 (Botus et al., 2010) , and the diagnostic titer was taken to be 396 to 400, equivalent to 2.6 log 10 (Fahey et al., 1987; Botus et al., 2010; IDEXX ELISA kit) .
RESULTS
Effect of Stinging Nettle and Neem on Immune Response to the Local Inactivated K1 Infectious Bursal Disease Vaccine
Both stinging nettle and neem had demonstrable humoral response-enhancing effects among the local inactivated K1 IBD vaccinated birds, as observed in Groups 1B and 1C showing higher antibody titers compared to the non-supplemented Group 1A (K1) (Table 2). However, stinging nettle supplemented birds in Group 1B had a faster onset of antibody responses of 3.01 log 10 as early as 2 wk post vaccination and the highest antibody titers in the entire period (Table 2 ). There were significant differences (P = 0.04) in antibody titers between 1A (given K1) and Group 2B (given D78+K1) and between (P = 0.005) Group 1A (given K1) and Group 2C (given D78+K1) at 2 wk post primary vaccination.
Effect of Stinging Nettle and Neem on Immune Response to Combinations of the Local Inactivated K1 and Imported Live D78 Infectious Bursal Disease Vaccines
Stinging nettle had better humoral immune response enhancing effects in groups receiving a combination of the 2 IBD vaccines (2B and 2C) compared to neem (2A) ( Table 2) . Groups 2B and 2C (given D78+K1 + S.Nettle) had greatly enhanced mean weekly antibody titers of 3.185 log 10 and 3.7 log 10 , respectively, which were beyond the threshold antibody titer level of 3.18 log 10 as early as 2 wk post primary vaccination ( Table 2) . At 3 wk post primary vaccination, stinging nettle supplemented Groups 2C (D78 +K1), 1B (K1), and 2B (D78+K1) had the highest mean antibody titers of 3.955 log 10 , 3.945 log 10 , and 3.858 log 10 , respectively ( Table 2 ). The same trend was observed at 4 wk post vaccination, with the same Groups 2C, 2B, and 1B recording the highest mean weekly antibody titers of 3.918 log 10 , 3.865 log 10 , and 3.753 log 10 , respectively (Table 2) . At 6 wk, Group 2B had the highest mean antibody titer of 3.913 log 10 followed by the neem supplemented Group 2A (D78 + K1) and the non-supplemented Group 3A, which had titer of 3.82 log 10 and 3.788 log 10 , respectively (Table 2) . Group 2B receiving a combination of the 2 IBD vaccines 30 d apart had more persistent antibody responses (levels >3.8 log 10 ) from the third wk to the last wk of the trial compared to Group 2C, receiving the same combination but on the same d, which had a faster induction of high antibody responses (beyond threshold titer in the second wk) but showed a decline from the sixth wk (Table 2) . (Fahey et al., 1987; Botus et al., 2010; IDEXX kit) , § = antibody titer above which birds were assumed to be protected from IBDV (Botus et al., 2010; WHO, 2013) At the end of the trial (wk 7), Group 2B (D78+K1), supplemented with stinging nettle, had the highest mean antibody titer of 4.103 log 10 followed by 3.835 log 10 of Group 2A (D78+K1), supplemented with neem, but both received a combination of the imported live D78 and local inactivated K1 IBD vaccines 30 d apart (Table 2) .
Overall Effect of Stinging Nettle and Neem on Immune Response to the 2 Infectious Bursal Disease Vaccines
Overall, groups vaccinated with either of the 2 IBD vaccines and supplemented with stinging nettle (IBD +S.Nettle [1B, 2B, 2C]) had enhanced antibody titers beyond the threshold titer of 3.18 log 10 as early as 2 wk post primary vaccinations compared to the neem supplemented groups (IBD +Neem [1C, 2A, 3B] ) and Groups 3A (D78) and 1A (K1) whose antibody titers were still below the threshold titer and attained it only one wk later at 3 wk ( Figure 1 , Table 2 ). Neem supplementation began showing humoral immune responseenhancing effects from the fifth week (Figure 1 ). In addition, vaccinated groups that were supplemented with stinging nettle had higher antibody titers compared to the neem supplemented and non-supplemented groups (Figure 1) . However, there were no significant differences (P = 0.17) in the combined antibody titerenhancing effects between stinging nettle and neem groups.
The imported live D78 IBD vaccine (Group 3A) induced relatively higher antibody titers compared to the local inactivated K1 IBD vaccine (Group 1A) ( Figure 1 , Table 2 ). However, there were no significant differences (P = 0.22) in mean IBD antibody titers between Group 3A (D78) and 1A (K1) receiving the imported live and local inactivated IBD vaccines, respectively.
DISCUSSION
Humoral immunity to infectious bursal disease vaccination is considered an important factor in protecting chickens from developing clinical signs of the disease (Kim et al., 2000) . However, cell mediated responses also may be involved (Fussell, 1998; Kim et al., 2000) . Thus, currently, IBDV vaccines used in commercial flocks are selected on their ability to induce vigorous antibody responses (Kim et al., 2000) . Stinging nettle (Urtica dioica) supplemented groups (2C and 2B) receiving a combination of the 2 IBD vaccines demonstrated early onset (2 wk) and a rapid and higher ELISA antibody response compared to groups receiving the same combination and supplemented with neem (Azadirachta indica). The immune stimulatory activity of stinging nettle can be attributed the compounds quercetin-3-O-rutinoside, isorhamnetin-3-O-glucoside, and kaempherol-3-O-rutinoside and mannose-specific plant lectins, which have the multi-binding characteristics resembling those of IgM, as explained by Kausik et al. (2012) and Joshi et al. (2014) . Further, stinging nettle is a rich source of a super lectin, (Urtica dioica agglutinin), potent polysaccharides (glucans), and caffeic malic acid, which is reported to act by switching Th-1 derived response to Th-2 response and, therefore, inhibiting inflammatory responses and promoting antibody production (Seliya and Kothiyal, 2014) . This should, however, be further confirmed at the molecular level by cytokine expression patterns.
Groups receiving a combination of the imported live D78 and local inactivated (K1) IBD vaccines (2C, 2A, and 2B) had the highest antibody titers at 2 and 6 wk post primary vaccinations, suggesting a more superior serological potency and vaccination regime. This can be attributed to the fact that such combinations of live and inactivated vaccine elicit simultaneous upregulation of expression of Th-1 and Th-2 cytokine responses geared towards effective elimination of the infection and production of memory B-and T-cells (Siegrist, 2007) . It can further be attributed to the close spacing (same d) of the primary combined IBD vaccine doses in these groups, resulting in a rapid induction of antibody production as early as 2 wk post vaccination to levels above the threshold titer of 3.18 log 10 (Botus et al., 2010) and concurs with the explanations of Siegrist (2007) . However, this induced less persisting antibody responses than when the same number of vaccine doses was given at longer (30 d apart) intervals, reflecting the generation of fewer post-germinal center B-cells capable of long-term survival and thus requiring later boosting, as explained by Siegrist (2007) and in agreement with the findings of Jeurissen et al. (1998) and Lone et al. (2012) . The best IBD vaccination regime for indigenous chickens would therefore comprise a prime-boost program combining imported live and local inactivated IBD vaccines given on the same d (for faster onset of high titers) or allowing a 30-day interval to elapse between priming and booster doses (for persistent antibody responses or long-term efficacy), as established by this study.
Aqueous neem (Azadirachta indica) supplementation (Group 2A) also had demonstrable humoral responseenhancing effects among the local inactivated K1 vaccinated birds that can be attributed to soluble plant glycans and lectins, e.g., mannose-specific plant carbohydrate binding agents, such as concanavalin A, nimbin, azadirachtin, salanin, and jacalin (Kausik et al., 2012; Jawad et al., 2013) . These findings on neem concur with those of Kausik et al. (2012) who also reported higher IgM and IgG levels along with increased titer of antiovalbumin antibody when neem leaf extract was orally fed at 100 mg/kg. However, this response was demonstrable only after a delay of about 3 wk (Kausik et al., 2012) compared to the 4-week delay observed in indigenous chickens by this study. The humoral responseenhancing effects observed with neem in this study are further in agreement with the findings of Sadekar et al. (1998) and Jawad et al. (2013) , who fed powdered dry leaves of neem (A. indica) in feed at 2 g/kg to broilers despite the different routes of administration. This immunostimulant activity of neem also may be mediated by selective activation of cell-mediated immune mechanisms to elicit an enhanced response to subsequent vaccine or antigenic challenge (Kausik et al., 2012) .
The imported live D78 vaccine showed relatively higher but non-statistically different ELISA antibody titera compared to the local inactivated K1 IBD vaccine. This could indicate a low antigen content, especially viral protein-2 (VP2) content of the local inactivated IBD vaccine, which is considered the most important factor determining the antibody titers after vaccination with inactivated vaccines (Maas et al., 2004; Jansen et al., 2007) . The resultant lower titer seen with the local inactivated K1 IBD vaccine in Group 1A can be further attributed to lack of an adjuvant and formaldehyde inactivation, which has been reported to be capable of modifying IBD virus immunogenic sites on VP2, leading to poor immune responses (Kibenge et al., 1988; Delrue et al., 2012) . This calls for an alternative inactivation agent to ensure antigenic fidelity and an appropriate adjuvant to maintain antigens at the injection site and provide the "danger" signals that facilitate uptake by antigen-presenting cells (Van den Berg et al., 2000; Jansen et al., 2007) . However, the local inactivated IBD vaccine (K1) was able to surpass the threshold antibody titer level of 1,500 (Botus et al., 2010) at 3 wk post primary vaccination, demonstrating its serological potency and immunogenicity in indigenous chickens. These findings are in agreement with those of El-Bagoury et al. (2015) who found similar increases in antibody titer from the third wk post vaccination when SPF chicks were vaccinated with a local isolates-derived inactivated IBD vaccine. Live attenuated vaccines generally stimulate a higher intensity of innate immune activation and responses, due to a higher antigen content following replication and the more prolonged antigen persistence, resulting in higher antibody responses and memory cell production to live than inactivated vaccines (Hedayati et al., 2005; Siegrist, 2007) . This explains the higher immunogenicity and persistence of antibody responses to the imported live attenuated D78 vaccine compared to the local inactivated K1 IBD vaccine, as found by this study. Similar findings also have been reported by Bose et al. (2003) and Hedayati et al. (2005) with IBD vaccines. While the antibody response to the imported IBD vaccine (D78 strain) has been shown to be relatively optimal, it is still puzzling why farmers who vaccinated flocks in Kwale, Kenya, failed to get demonstrable antibodies to imported IBD vaccines, leading to outbreaks of IBD in vaccinated flocks (Mutinda et al., 2014) .
In conclusion, drinking water supplementation of 1% stinging nettle and neem improves humoral immune responses to both live and killed IBD vaccines, thereby ensuring establishment of a good immune foundation in indigenous chickens. These stimulants have the potential to mitigate for the reported poor immune responses to IBD vaccination and to reduce or eliminate mortalities to IBDV challenge in vaccinated flocks. The best vaccination regime for indigenous chickens should comprise a combination of the 2 IBD vaccines in a prime-boost program plus supplementation with either stinging nettle or neem. The candidate local inactivated K1 vaccine should be further evaluated for protection of indigenous chickens against challenge with virulent IBDV and developed into a fully licensed vaccine.
SUPPLEMENTARY DATA
Supplementary data are available at Poultry Science online.
